1	Expression	expression	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	nucleus	nucleus	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	peripheral	peripheral	_	_	_	_	_	_	_
10	blood	blood	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	lymphocytes	lymphocyte	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	According	accord	_	_	_	_	_	_	_
2	to	to	_	_	_	_	_	_	_
3	current	current	_	_	_	_	_	_	_
4	models	model	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	inhibitory	inhibitory	_	_	_	_	_	_	_
7	capacity	capacity	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	I(kappa)B(alpha)	I(kappa)B(alpha)	_	_	_	_	_	_	_
10	would	would	_	_	_	_	_	_	_
11	be	be	_	_	_	_	_	_	_
12	mediated	mediate	_	_	_	_	_	_	_
13	through	through	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	retention	retention	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	Rel/NF-kappaB	Rel/NF-kappaB	_	_	_	_	_	_	_
18	proteins	protein	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	cytosol	cytosol	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	I(kappa)B(alpha)	I(kappa)B(alpha)	_	_	_	_	_	_	_
4	has	have	_	_	_	_	_	_	_
5	also	also	_	_	_	_	_	_	_
6	been	be	_	_	_	_	_	_	_
7	detected	detect	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	nucleus	nucleus	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	cell	cell	_	_	_	_	_	_	_
13	lines	line	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	when	when	_	_	_	_	_	_	_
16	overexpressed	overexpresse	_	_	_	_	_	_	_
17	by	by	_	_	_	_	_	_	_
18	transient	transient	_	_	_	_	_	_	_
19	transfection	transfection	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	gain	gain	_	_	_	_	_	_	_
3	better	good	_	_	_	_	_	_	_
4	insight	insight	_	_	_	_	_	_	_
5	into	into	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	potential	potential	_	_	_	_	_	_	_
8	role	role	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	nuclear	nuclear	_	_	_	_	_	_	_
11	I(kappa)B(alpha)	i(kappa)b(alpha)	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	physiological	physiological	_	_	_	_	_	_	_
15	context	context	_	_	_	_	_	_	_
16	we	we	_	_	_	_	_	_	_
17	have	have	_	_	_	_	_	_	_
18	analysed	analyse	_	_	_	_	_	_	_
19	its	its	_	_	_	_	_	_	_
20	presence	presence	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	nucleus	nucleus	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	human	human	_	_	_	_	_	_	_
26	peripheral	peripheral	_	_	_	_	_	_	_
27	blood	blood	_	_	_	_	_	_	_
28	T	t	_	_	_	_	_	_	_
29	lymphocytes	lymphocyte	_	_	_	_	_	_	_
30	(	(	_	_	_	_	_	_	_
31	PBL	PBL	_	_	_	_	_	_	_
32	)	)	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	demonstrate	demonstrate	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	nuclear	nuclear	_	_	_	_	_	_	_
5	localization	localization	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	I(kappa)B(alpha)	I(kappa)B(alpha)	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	PBL	PBL	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	different	different	_	_	_	_	_	_	_
12	techniques	technique	_	_	_	_	_	_	_
13	:	:	_	_	_	_	_	_	_
14	Western	western	_	_	_	_	_	_	_
15	blot	blot	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	indirect	indirect	_	_	_	_	_	_	_
18	immunofluorescence	immunofluorescence	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	electron	electron	_	_	_	_	_	_	_
21	microscopy	microscopy	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Low	low	_	_	_	_	_	_	_
2	levels	level	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	nuclear	nuclear	_	_	_	_	_	_	_
5	I(kappa)B(alpha)	i(kappa)b(alpha)	_	_	_	_	_	_	_
6	were	be	_	_	_	_	_	_	_
7	detected	detect	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	resting	rest	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	whereas	whereas	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	superinduction	superinduction	_	_	_	_	_	_	_
14	was	be	_	_	_	_	_	_	_
15	obtained	obtain	_	_	_	_	_	_	_
16	after	after	_	_	_	_	_	_	_
17	PMA	PMA	_	_	_	_	_	_	_
18	activation	activation	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	nuclear	nuclear	_	_	_	_	_	_	_
3	pool	pool	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	I(kappa)B(alpha)	I(kappa)B(alpha)	_	_	_	_	_	_	_
6	showed	show	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	higher	high	_	_	_	_	_	_	_
9	stability	stability	_	_	_	_	_	_	_
10	than	than	_	_	_	_	_	_	_
11	cytosolic	cytosolic	_	_	_	_	_	_	_
12	I(kappa)B(alpha)	i(kappa)b(alpha)	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	was	be	_	_	_	_	_	_	_
15	partially	partially	_	_	_	_	_	_	_
16	independent	independent	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	resynthesis	resynthesis	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	protein	protein	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Unexpectedly	unexpectedly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	presence	presence	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	nuclear	nuclear	_	_	_	_	_	_	_
7	I(kappa)B(alpha)	i(kappa)b(alpha)	_	_	_	_	_	_	_
8	did	do	_	_	_	_	_	_	_
9	not	not	_	_	_	_	_	_	_
10	inhibit	inhibit	_	_	_	_	_	_	_
11	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
12	binding	binding	_	_	_	_	_	_	_
13	to	to	_	_	_	_	_	_	_
14	DNA	DNA	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	this	this	_	_	_	_	_	_	_
17	phenomenon	phenomenon	_	_	_	_	_	_	_
18	was	be	_	_	_	_	_	_	_
19	not	not	_	_	_	_	_	_	_
20	due	due	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	presence	presence	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	IkappaBbeta	IkappaBbeta	_	_	_	_	_	_	_
26	at	at	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	nuclear	nuclear	_	_	_	_	_	_	_
29	level	level	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Immunoprecipitation	Immunoprecipitation	_	_	_	_	_	_	_
2	experiments	experiment	_	_	_	_	_	_	_
3	failed	fail	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	demonstrate	demonstrate	_	_	_	_	_	_	_
6	an	an	_	_	_	_	_	_	_
7	association	association	_	_	_	_	_	_	_
8	between	between	_	_	_	_	_	_	_
9	nuclear	nuclear	_	_	_	_	_	_	_
10	I(kappa)B(alpha)	i(kappa)b(alpha)	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
13	proteins	protein	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	demonstrate	demonstrate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	resting	rest	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	PMA-activated	pma-activated	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	PBL	PBL	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	I(kappa)B(alpha)	I(kappa)B(alpha)	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	present	present	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	nucleus	nucleus	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	an	an	_	_	_	_	_	_	_
20	apparently	apparently	_	_	_	_	_	_	_
21	inactive	inactive	_	_	_	_	_	_	_
22	form	form	_	_	_	_	_	_	_
23	unable	unable	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	disrupt	disrupt	_	_	_	_	_	_	_
26	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
27	binding	binding	_	_	_	_	_	_	_
28	from	from	_	_	_	_	_	_	_
29	DNA	DNA	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

